Clinical Trial Approval and Ethical Committee Framework – pv pharmacovigilance

Clinical Trial Approval and Ethical Committee Framework – pv pharmacovigilance Clinical Trial Approval and Ethical Committee Framework – pv pharmacovigilance In the context of clinical research, pv pharmacovigilance plays a pivotal role in ensuring the safety and efficacy of therapeutic products. This comprehensive guide aims to provide a structured approach to obtaining approval for clinical trials in Lebanon through the Ministry of Public Health (MOH). It delineates the steps from the initial planning phase to post-approval obligations, all while ensuring compliance with international regulatory standards. Step 1: Understanding Regulatory Framework and Requirements Before embarking on the process of clinical trial…

Continue Reading... Clinical Trial Approval and Ethical Committee Framework – pv pharmacovigilance

Accepted Dossier Formats: CTD vs. Country-Specific Templates – regulatory affairs science

Accepted Dossier Formats: CTD vs. Country-Specific Templates – regulatory affairs science Accepted Dossier Formats: CTD vs. Country-Specific Templates for Regulatory Affairs Science The preparation and submission of regulatory documents is a crucial aspect of pharmaceutical development and approval. This article serves as a comprehensive guide to understanding the differences between the Common Technical Document (CTD) and country-specific templates, particularly in the context of Lebanon’s Ministry of Public Health (MOH). Adhering to the appropriate dossier format is imperative for successful regulatory affairs management. This guide will be beneficial for pharmaceutical professionals involved in the regulatory affairs science domain, including Quality Assurance…

Continue Reading... Accepted Dossier Formats: CTD vs. Country-Specific Templates – regulatory affairs science

Pharmaceutical Registration Procedure in Lebanon – scientific regulatory affairs

Pharmaceutical Registration Procedure in Lebanon – scientific regulatory affairs Pharmaceutical Registration Procedure in Lebanon: A Step-by-Step Guide The pharmaceutical industry in Lebanon, like in many countries, is structurally regulated by its Ministry of Public Health (MOH). This article outlines the required steps for pharmaceutical registration in Lebanon, aiming to provide regulatory affairs professionals with a practical roadmap. This guide adheres closely to relevant regulatory frameworks, ensuring an accurate and compliant approach to the registration procedure. Step 1: Understanding the Regulatory Framework The regulatory landscape in Lebanon is primarily governed by the Ministry of Public Health (MOH), which enforces laws that…

Continue Reading... Pharmaceutical Registration Procedure in Lebanon – scientific regulatory affairs

Overview of Lebanon’s MOH and Its Drug Regulatory Role – regulatory science

Overview of Lebanon’s MOH and Its Drug Regulatory Role – regulatory science Overview of Lebanon’s MOH and Its Drug Regulatory Role This article provides a comprehensive, step-by-step guide on Lebanon’s Ministry of Public Health (MOH) and its vital role in regulating drugs. The focus is on understanding the regulatory framework, dossier preparation, Good Manufacturing Practice (GMP) requirements, pharmacovigilance (PV), and approval timelines. This tutorial targets professionals engaged in regulatory affairs, quality assurance, pharmacovigilance, and related scientific regulatory affairs. Understanding Lebanon’s Drug Regulatory Framework Lebanon’s regulatory landscape concerning pharmaceuticals is primarily governed by the Ministry of Public Health (MOH). Recognizing the…

Continue Reading... Overview of Lebanon’s MOH and Its Drug Regulatory Role – regulatory science

Practical Tips for Regulatory Success in Iraq’s Public and Private Sectors – regulatory affairs for biomaterials and medical devices

Practical Tips for Regulatory Success in Iraq’s Public and Private Sectors – regulatory affairs for biomaterials and medical devices Practical Tips for Regulatory Success in Iraq’s Public and Private Sectors – regulatory affairs for biomaterials and medical devices The regulatory landscape for biomaterials and medical devices in Iraq’s public and private sectors requires a comprehensive understanding of specific guidelines set out by the Ministry of Health (MOH) and the Central Organization for Standardization and Quality Control (COSQC). This article will serve as a step-by-step tutorial, guiding regulatory affairs teams, quality control professionals, and clinical research personnel through essential phases to…

Continue Reading... Practical Tips for Regulatory Success in Iraq’s Public and Private Sectors – regulatory affairs for biomaterials and medical devices

Product Recall, Enforcement, and Compliance Monitoring – department of regulatory affairs

Product Recall, Enforcement, and Compliance Monitoring – department of regulatory affairs Product Recall, Enforcement, and Compliance Monitoring – department of regulatory affairs Step 1: Understanding the Role of the Department of Regulatory Affairs The first step in navigating the complexities of product recall, enforcement, and compliance monitoring in Iraq involves a comprehensive understanding of the department of regulatory affairs. This department is responsible for the regulation and oversight of medicinal products and medical devices within the jurisdiction of the Ministry of Health (MOH) and KIMADIA, the central medical procurement entity. The department of regulatory affairs ensures that all marketed products…

Continue Reading... Product Recall, Enforcement, and Compliance Monitoring – department of regulatory affairs

Overview of E-submission or Paper-based Filing Practices – pharmaceutical industry regulatory affairs

Overview of E-submission or Paper-based Filing Practices – pharmaceutical industry regulatory affairs Overview of E-submission or Paper-based Filing Practices – pharmaceutical industry regulatory affairs Step 1: Understanding the Regulatory Framework in Iraq Before engaging in any pharmaceutical industry regulatory affairs, it is crucial to fully understand the regulatory framework provided by the Iraqi Ministry of Health (MOH) and the KIMADIA (the Iraqi Central Agency for Medicines and Medical Appliances). The foundational elements of this framework govern all operations related to the approval and post-marketing compliance of pharmaceutical products. This understanding encompasses local laws, international guidelines, and how they intertwine with…

Continue Reading... Overview of E-submission or Paper-based Filing Practices – pharmaceutical industry regulatory affairs

Iraq’s Role in Regional Procurement and Regulatory Alliances – regulatory affairs in pharmaceutical industry

Iraq’s Role in Regional Procurement and Regulatory Alliances – Regulatory Affairs in Pharmaceutical Industry Iraq’s Role in Regional Procurement and Regulatory Alliances – Regulatory Affairs in Pharmaceutical Industry The pharmaceutical industry operates within a highly regulated environment where adhering to established guidelines is essential for the approval and market entry of medicinal products. Iraq, under the guidance of the Ministry of Health (MOH) and KIMADIA (the Central Organization for Standardization and Quality Control), plays a pivotal role in the regional procurement and regulatory framework for pharmaceutical products. This article outlines a step-by-step tutorial guide focused on the key phases of…

Continue Reading... Iraq’s Role in Regional Procurement and Regulatory Alliances – regulatory affairs in pharmaceutical industry

Cosmetic Product Registration and Marketing Controls – pharmaceutical industry regulatory affairs

Cosmetic Product Registration and Marketing Controls – pharmaceutical industry regulatory affairs Cosmetic Product Registration and Marketing Controls: A Step-by-Step Guide for Pharmaceutical Industry Regulatory Affairs The regulatory landscape surrounding cosmetic products in Iraq, governed by the Ministry of Health (MOH) and KIMADIA, is critical for industry professionals involved in pharmaceutical industry regulatory affairs. Understanding this framework is essential for ensuring compliance, effective product launch, and maintaining market presence. This tutorial will provide a comprehensive roadmap for the registration and marketing controls of cosmetic products in Iraq, structured into clear, actionable steps. Step 1: Understanding Regulatory Framework The first crucial phase…

Continue Reading... Cosmetic Product Registration and Marketing Controls – pharmaceutical industry regulatory affairs

Regulation of Food Supplements and Nutritional Products – regulatory affairs in pharma industry

Regulation of Food Supplements and Nutritional Products – regulatory affairs in pharma industry Regulation of Food Supplements and Nutritional Products – regulatory affairs in pharma industry The regulation of food supplements and nutritional products in Iraq is governed by the Ministry of Health (MOH) and its affiliated agency, KIMADIA. With the objective of ensuring public health and safety while promoting fair practices in the market, understanding the regulatory framework is essential for pharmaceutical industry professionals involved in regulatory affairs. This step-by-step tutorial guide aims to provide a structured approach to navigating the complexities of regulatory affairs in the pharmaceutical industry…

Continue Reading... Regulation of Food Supplements and Nutritional Products – regulatory affairs in pharma industry